Wonder Club world wonders pyramid logo
×

Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda Book

Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda
Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda, Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic , Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda has a rating of 4 stars
   2 Ratings
X
Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda, Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic , Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda
4 out of 5 stars based on 2 reviews
5
50 %
4
0 %
3
50 %
2
0 %
1
0 %
Digital Copy
PDF format
1 available   for $99.99
Original Magazine
Physical Format

Sold Out

  • Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda
  • Written by author Molla S. Donaldson
  • Published by National Academies Press, 1993/01/01
  • Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic
Buy Digital  USD$99.99

WonderClub View Cart Button

WonderClub Add to Inventory Button
WonderClub Add to Wishlist Button
WonderClub Add to Collection Button

Book Categories

Authors

Summary 1
Cross-Cutting Recommendations 2
Uses of Antiprogestins: The Reproductive Cycle 3
Other Potential Therapeutic Uses of Antiprogestins 8
Antiglucocorticoid Effects of Antiprogestins 13
1 Introduction 14
Background and Historical Perspectives 14
The IOM Report 17
Cross-Cutting Recommendations 17
2 Uses of Antiprogestins: The Reproductive Cycle (Part I) 19
Contraception 20
Post-Coital Contraception 22
Menses Induction 23
3 Uses of Antiprogestins: The Reproductive Cycle (Part II) 26
Pregnancy Termination During the First Trimester 26
Pregnancy Termination During the Second Trimester 30
Cervical Ripening 32
Labor Induction in Late Pregnancy 33
Summary 34
4 Other Therapeutic Uses of Antiprogestins 36
Endometriosis 36
Uterine Leiomyomas (Fibroids) 39
Breast Cancer 41
Meningiomas 48
5 Antiglucocorticoid Effects of Antiprogestins 52
Glucocorticoid Function 52
Therapeutic Use of Mifepristone (RU 486) as an Antiglucocorticoid 53
Adverse Antiglucocorticoid Effects of Antiprogestins 55
6 Animals as Models for Studying Antiprogestins 57
App. A: Agenda for the IOM Workshop "Antiprogestins: Assessing the Science" 65
App. B: Background Papers and Presentations (In Order of Presentation at IOM Workshop) 69
B1 1993: RU 486 - A Decade on Today and Tomorrow 71
B2 Overview and Background: Mechanism of Action of Antiprogestins 120
B3 The Use of Antiprogestins in the Reproductive Cycle 139
B4 Potential Contraceptive Effects of Antigestogens 148
B5 Use of Antiprogestins Before 63 Days of Amenorrhea 164
B6 Uses of Antiprogestins After 63 Days of Amenorrhea 174
B7 Comments on Session II 183
B8 Use of Antiprogestins in the Management of Endometriosis and Leiomyoma 189
B9 Antiprogestins and the Treatment of Breast Cancer 210
B10 Uses of RU 486 as an Antiglucocorticoid 229
B11 Primate Models for the Study of Antiprogestins in Reproductive Medicine 243
B12 Antiprogestogens: Perspectives from a Global Research Program 253
App. C: Observers at the Workshop on Antiprogestins 278
Index 281


Login

  |  

Complaints

  |  

Blog

  |  

Games

  |  

Digital Media

  |  

Souls

  |  

Obituary

  |  

Contact Us

  |  

FAQ

CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!!

X
WonderClub Home

This item is in your Wish List

Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda, Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic , Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda

X
WonderClub Home

This item is in your Collection

Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda, Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic , Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda

Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda

X
WonderClub Home

This Item is in Your Inventory

Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda, Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic , Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda

Clinical Applications of Mifepristone Assessing the Science and Recommending a Research Agenda

WonderClub Home

You must be logged in to review the products

E-mail address:

Password: